| tenofovir disoproxil fumarate / Generic mfg. |
NCT02908191: A Study in Healthy Volunteers and Patients With Chronic Hepatitis B |
|
|
| Completed | 1a/1b | 86 | RoW | ABI-H0731, Placebo for ABI-H0731, Sugar pill manufactured to mimic the ABI-H0731 tablet, Entecavir, Tenofovir disoproxil fumarate, Pegasys, peginterferon alfa-2a, Nucleos(t)ide | Assembly Biosciences | Chronic Hepatitis B | 03/18 | 06/18 | | |
NCT01671787: A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B |
|
|
| Completed | 1b | 51 | Canada, US, Europe, RoW | GS-7340, Tenofovir disoproxil fumarate, Viread | Gilead Sciences | Chronic Hepatitis B | 04/13 | 04/13 | | |
NCT00828789: VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer |
|
|
| Completed | 1 | 20 | RoW | Efavirenz; Tenofovir disoproxil fumarate; Telaprevir | Tibotec BVBA | Hepatitis C, HCV, HIV, AIDS | 04/09 | 04/09 | | |
NCT01205139: TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir |
|
|
| Completed | 1 | 48 | Europe | TMC435, TDF, TMC435 + TDF, TMC435 + TMC278, TMC278 | Tibotec Pharmaceuticals, Ireland | Hepatitis C Virus | 03/11 | 03/11 | | |
NCT01480622: Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects |
|
|
| Completed | 1 | 14 | RoW | TDF tablets | GlaxoSmithKline | Hepatitis B, Chronic | 12/11 | 12/11 | | |
NCT02557594: Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers |
|
|
| Completed | 1 | 36 | RoW | Viread 300mg, Tenofovir disoproxil fumarate, DA-2802 319mg, Tenofovir disoproxil orotate | Dong-A ST Co., Ltd. | Healthy | 11/15 | 03/16 | | |
NCT02589457: Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet |
|
|
| Completed | 1 | 40 | RoW | CKD-390, Viread® tablet | Chong Kun Dang Pharmaceutical | Chronic Hepatitis B | 12/15 | 12/15 | | |
NCT02920931: A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers |
|
|
| Completed | 1 | 50 | RoW | Tenofovir disoproxil | Boryung Pharmaceutical Co., Ltd | Hepatitis | 04/16 | 04/16 | | |
NCT03032536: Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers |
|
|
| Terminated | 1 | 54 | RoW | AL-3778, NVR 3-778, JNJ-63595948, ALS-003778, Entecavir, Tenofovir disoproxil fumarate, Viread | Alios Biopharma Inc. | Hepatitis B, Chronic Hepatitis B, Viral Hepatitis B | 06/17 | 06/17 | | |
